▶ 調査レポート

消化管間質腫瘍（GIST）治療のアジア市場：市場規模・シェア・価格・動向・予測
• 英文タイトル：Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Prof Researchが調査・発行した産業分析レポートです。消化管間質腫瘍（GIST）治療のアジア市場：市場規模・シェア・価格・動向・予測 / Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast / D0FB0641060資料のイメージです。• レポートコード：D0FB0641060
• 出版社/出版日：Prof Research / 2019年12月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、146ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥420,000 (USD3,000)▷ お問い合わせ
  Site License￥532,000 (USD3,800)▷ お問い合わせ
  Global Site License￥700,000 (USD5,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
消化管間質腫瘍（GIST）治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は消化管間質腫瘍（GIST）治療の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける消化管間質腫瘍（GIST）治療市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。
・市場概要
・産業チェーン分析（ファイブフォース分析、コスト構造分析）
・市場動向
・消化管間質腫瘍（GIST）治療のアジア市場規模推移2014-2019
・消化管間質腫瘍（GIST）治療のアジア市場規模予測2019-2024
・消化管間質腫瘍（GIST）治療のサプライヤー分析
・顧客（需要先）分析
・主要企業分析（Pfizer、Bayer、Novartis、Immunicum、Roche、AB Science、Arog Pharmaceuticals、Boston Biomedical、Sun Pharmaceutical、Natco Pharma）
・結論

Abstract:

The Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.

This report is an essential reference for who looks for detailed information on Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Gastrointestinal Stromal Tumors (GISTs) Treatment market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.

Key Points of this Report:

* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Gastrointestinal Stromal Tumors (GISTs) Treatment
* It describes present situation, historical background and future forecast
* Comprehensive data showing Gastrointestinal Stromal Tumors (GISTs) Treatment capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Gastrointestinal Stromal Tumors (GISTs) Treatment manufacturers
* Gastrointestinal Stromal Tumors (GISTs) Treatment market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us

The largest vendors of Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment market: (At least 10 companies included)
* Pfizer
* Bayer
* Novartis
* Immunicum
* Roche
* AB Science
For complete list, please ask for sample pages.

The Gastrointestinal Stromal Tumors (GISTs) Treatment market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand

The reports analysis Gastrointestinal Stromal Tumors (GISTs) Treatment market in Asia Pacific by products type:
* Type I
* Type II
* Type III

The reports analysis Gastrointestinal Stromal Tumors (GISTs) Treatment market in Asia Pacific by application as well:
* Application I
* Application II
* Application III

Reasons to Purchase this Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

Table of Contents

Chapter One Gastrointestinal Stromal Tumors (GISTs) Treatment Overview
1.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Outline
1.2 Classification and Application
1.3 Manufacturing Technology

Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis

Chapter Three Market Dynamics of Gastrointestinal Stromal Tumors (GISTs) Treatment Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges

Chapter Four Asia Pacific Market of Gastrointestinal Stromal Tumors (GISTs) Treatment (2014-2019)
4.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Supply
4.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis

Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Supply
5.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis

Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation

Chapter Seven Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis

Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Pfizer
8.2 Bayer
8.3 Novartis
8.4 Immunicum
8.5 Roche
……
……

Chapter Nine Research Conclusions of Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Industry

Tables and Figures

Figure Commercial Product of Gastrointestinal Stromal Tumors (GISTs) Treatment
Table Classification of Gastrointestinal Stromal Tumors (GISTs) Treatment
Table Application of Gastrointestinal Stromal Tumors (GISTs) Treatment
Figure Porter Five Forces Model Analysis of Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment
Figure Production Cost Analysis of Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment
Table Gastrointestinal Stromal Tumors (GISTs) Treatment Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity List
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production List
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Production Value and Growth Rate
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Gastrointestinal Stromal Tumors (GISTs) Treatment
Table 2014-2019 Asia Pacific Import and Export of Gastrointestinal Stromal Tumors (GISTs) Treatment
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Demand List by Application
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Demand by Application
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Demand Share List by Application
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Demand Share by Application
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Country-wise Consumption List
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Country-wise Consumption
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Country-wise Consumption Share
Table 2014-2019 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity List
Table 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production List
Table 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Gastrointestinal Stromal Tumors (GISTs) Treatment
Table 2019-2024 Asia Pacific Import and Export of Gastrointestinal Stromal Tumors (GISTs) Treatment
Table 2019-2024 Asia Pacific Demand of Gastrointestinal Stromal Tumors (GISTs) Treatment by Application
Figure 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Demand by Application
Table 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Demand Share List by Application
Figure 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Demand Share by Application
Table 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Country-wise Consumption List
Figure 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Country-wise Consumption
Table 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Country-wise Consumption Share
Table 2019-2024 Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Gastrointestinal Stromal Tumors (GISTs) Treatment Raw Material Suppliers
Table Key End Users List
Table Profile of Pfizer
Table SWOT Analysis of Pfizer
Table Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Product Specification
Table 2014-2019 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production and Growth Rate
Figure 2014-2019 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Production Global Market Share
Table SWOT Analysis of Bayer
Figure Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Products
Table 2014-2019 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production and Growth Rate
Figure 2014-2019 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Production Global Market Share
Table SWOT Analysis of Novartis
Figure Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Product Specification
Table 2014-2019 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production and Growth Rate
Figure 2014-2019 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Production Global Market Share
Table Profile of Immunicum
Table SWOT Analysis of Immunicum
Figure Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Product Specification
Table 2014-2019 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production and Growth Rate
Figure 2014-2019 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Production Global Market Share
Table Profile of Roche
Table SWOT Analysis of Roche
Figure Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Product
Table 2014-2019 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Capacity Production and Growth Rate
Figure 2014-2019 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Production Global Market Share
……
……


以下、関連資料のご紹介
  • 消化管間質腫瘍（GIST）薬のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0641061 2019年12月 150Pages
    消化管間質腫瘍（GIST）薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は消化管間質腫瘍（GIS...
  • 消化器癌治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Gastrointestinal Cancer Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0641064 2019年12月 139Pages
    消化器癌治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は消化器癌治療の市場概要、産業チェーン、...
  • 性索性腺間質腫瘍治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Sex Cord Gonadal Stromal Tumor Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0630469 2019年12月 141Pages
    性索性腺間質腫瘍治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は性索性腺間質腫瘍治療の市場概要...
  • 異染性白質ジストロフィー（MLD）治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Metachromatic Leukodystrophy Mld Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0636399 2019年12月 136Pages
    異染性白質ジストロフィー（MLD）治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は異染性白質ジ...
  • 骨髄異形成症候群 (MDS) 治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Myelodysplastic Syndrome (MDS) Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0635409 2019年12月 136Pages
    骨髄異形成症候群 (MDS) 治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は骨髄異形成症候群...
  • 再発性多形性膠芽腫（GBM）治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Recurrent Glioblastoma Multiforme Gbm Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0631569 2019年12月 140Pages
    再発性多形性膠芽腫（GBM）治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は再発性多形性膠芽腫...
  • スタージウェーバー症候群（SWS）治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Sturge Weber Syndrome (SWS) Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0629106 2019年12月 144Pages
    スタージウェーバー症候群（SWS）治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書はスタージウェ...
  • 遅発性ジスキネジア（TD）治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Tardive Dyskinesia (TD) Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0628675 2019年12月 147Pages
    遅発性ジスキネジア（TD）治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は遅発性ジスキネジア（...
  • 水痘帯状疱疹ウイルス（VZV）治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Varicella-Zoster Virus (VZV) Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0627243 2019年12月 141Pages
    水痘帯状疱疹ウイルス（VZV）治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は水痘帯状疱疹ウイ...
  • 脊髄性筋萎縮症（SMA）治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Spinal Muscular Atrophy (SMA) Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0629467 2019年12月 150Pages
    脊髄性筋萎縮症（SMA）治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は脊髄性筋萎縮症（SMA...